1. 2023
  2. IgG Fab Glycans Hinder FcRn-Mediated Placental Transport

    Volkov, M., Brinkhaus, M., van Schie, K. A., Bondt, A., Kissel, T., van der Kooi, E. J., Bentlage, A. E. H., Koeleman, C. A. M., de Taeye, S. W., Derksen, N. I., Dolhain, R. J. E. M., Braig-Scherer, U., Huizinga, T. W. J., Wuhrer, M., Toes, R. E. M., Vidarsson, G. & van der Woude, D., 15 Jan 2023, In: Journal of immunology (Baltimore, Md.. 210, 2, p. 158-167 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2022
  4. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

    Brouwer, P. J. M., Antanasijevic, A., Ronk, A. J., Müller-Kräuter, H., Watanabe, Y., Claireaux, M., Perrett, H. R., Bijl, T. P. L., Grobben, M., Umotoy, J. C., Schriek, A. I., Burger, J. A., Tejjani, K., Lloyd, N. M., Steijaert, T. H., van Haaren, M. M., Sliepen, K., de Taeye, S. W., van Gils, M. J., Crispin, M., & 4 othersStrecker, T., Bukreyev, A., Ward, A. B. & Sanders, R. W., 14 Dec 2022, In: Cell host & microbe. 30, 12, p. 1759-1772.e12

    Research output: Contribution to journalArticleAcademicpeer-review

  5. At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity

    Oskam, N., Ooijevaar-de Heer, P., Derksen, N. I. L., Kruithof, S., de Taeye, S. W., Vidarsson, G., Reijm, S., Kissel, T., Toes, R. E. M. & Rispens, T., 1 Jul 2022, In: Journal of immunology (Baltimore, Md.. 209, 1, p. 16-25 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Immunoassay for quantification of antigen-specific IgG fucosylation

    Šuštić, T., van Coillie, J., Larsen, M. D., Derksen, N. I. L., Szittner, Z., Nouta, J., Wang, W., Damelang, T., Rebergen, I., Linty, F., Visser, R., Mok, J. Y., Geerdes, D. M., van Esch, W. J. E., de Taeye, S. W., van Gils, M. J., van de Watering, L., van der Schoot, C. E., Wuhrer, M., Rispens, T., & 1 othersVidarsson, G., 1 Jul 2022, In: EBioMedicine. 81, 104109.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions

    Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 16 May 2022, In: Frontiers in immunology. 13, 893648.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation

    van der Straten, K., van Gils, M. J., de Taeye, S. W. & de Bree, G. J., 2022, In: Frontiers in Medical Technology. 4, p. 867982 13 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  9. 2021
  10. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets

    Bye, A. P., Hoepel, W., Mitchell, J. L., Jégouic, S., Loureiro, S., Sage, T., Vidarsson, G., Nouta, J., Wuhrer, M., de Taeye, S., van Gils, M., Kriek, N., Cooper, N., Jones, I., den Dunnen, J. & Gibbins, J. M., 21 Oct 2021, In: Blood. 138, 16, p. 1481-1489 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 Next

ID: 51101